GeneTether Therapeutics Inc. (GNTTF) Stock Analysis
DELISTED
What happened to GeneTether Therapeutics Inc. (GNTTF) stock?
GeneTether Therapeutics Inc. (GNTTF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
GeneTether Therapeutics Inc. (GNTTF). GeneTether Therapeutics Inc. is a biotechnology company focused on developing precision gene editing technologies for human therapeutics. Their proprietary GeneTether platform aims to enhance the efficiency of gene-editing tools like CRISPR-Cas for treating rare, monogenic diseases.
Last analyzed: Mar 18, 2026GeneTether Therapeutics Inc. (GNTTF) Healthcare & Pipeline Overview
GNTTF OTC Market Information
GNTTF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy GNTTF shares?
No. GNTTF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for GNTTF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before GNTTF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to GeneTether Therapeutics Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.